Drugs Made In America Acquisition Corp. (DMAAU) Accumulated Expenses (2024 - 2025)

Drugs Made In America Acquisition (DMAAU) has 2 years of Accumulated Expenses data on file, last reported at $302623.0 in Q3 2025.

• Quarterly Accumulated Expenses changed N/A year-over-year to $302623.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $302623.0 (changed N/A YoY) and the FY2024 annual result came in at $77280.0, changed N/A from the prior year.
• Accumulated Expenses grew to $302623.0 in Q3 2025, from $147453.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $302623.0 in Q3 2025 to a low of $77280.0 in Q4 2024.